In 2018, Apotex sold its businesses in five European countries to Aurobindo for €74 million ($83 million) to focus on sales in the Americas. Editor's Note: This story has been updated to clarify the FDA's decision Wednesday. The FDA approved the voluntary withdrawal of 31 of Apotex's Abbreviated New Drug Applications.

Who bought Apotex?

Last year, Apotex sold its businesses in five European countries to Aurobindo for €74 million ($83 million). Apotex said the sale would allow it to focus on the Americas, where demand remains strong. The company employs more than 10,000 people in R&D, manufacturing and distribution worldwide.

Where are Apotex pharmaceuticals manufactured?

Although headquartered in Canada, Apotex manufacturers in India.